Neuregulin/MAPKs信号通路对NMDAR抗体介导的血脑屏障及大脑神经元损害的作用
批准号:
82060236
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
黄文
依托单位:
学科分类:
神经系统炎症、感染及相关疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
黄文
中文摘要
自身免疫性脑炎是由抗神经元细胞表面或突触蛋白的自身抗体引起的脑炎。2007年证实的NMDAR抗体是致病性神经元表面抗体,可引起复发和病死率均较高的抗NMDAR脑炎,然而其中的信号传导机制尚不明确,我们研究提示抗NMDAR脑炎患者预后与异常白蛋白指数和鞘内IgG合成相关,抑制ROCK通路可逆转NMDAR激动剂NMDA诱发的紧密连接蛋白Occludin破坏和血管通透性增加。本项目将通过抑制剂阻断MAPKs信号通路、CRISPR/Cas9基因敲除或激活质粒技术抑制或激活Occludin/Claudin-5或Neuregulin-1以研究脑血管内皮细胞HBEC-5i和NMDAR1/GluN1胞外肽段主动免疫或患者脑脊液提纯抗体被动免疫ApoE−/−小鼠中抗NMDAR抗体是否通过改变血脑屏障功能而损害大脑神经元及Neuregulin/MAPKs信号通路在其中的作用,为抗NMDAR脑炎防治提供新策略。
英文摘要
Autoimmune encephalitis is characterized by autoantibodies to surface epitopes of synaptic and cell surface proteins causing subacute deficits of memory and cognition, often followed by suppressed level of consciousness or coma. Anti-N-Methyl-D-Aspartate receptor (NMDAR) encephalitis with a high recurrence and fatality rate caused by NMDAR antibody identified in 2007. The underlying mechanism associated with signaling pathway of anti-NMDAR encephalitis is unclear. Our previous data indicated that the prognosis of patients with anti-NMDAR encephalitis is associated with abnormal cerebrospinal fluid/serum albumin ratio and 24-hour intrathecal IgG synthesis, and blocking Rho/ROCK signaling pathway by ROCK inhibitor Fasudil attenuated decreasing Occludin mRNA and protein levels and transepithelial electrical resistance induced by NMDAR agonist NMDA in the brain microvessel endothelial cells. This proposal will investigate the role of the disruption of tight junction protein to brain neuron lesions induced by NMDAR antibody as well as the effects of Neuregulin/MAPKs signaling pathway in human brain derived endothelial cells (HBEC-5i) and mice models in vivo immuned by NMDAR1/GluN1 peptides or cerebro-spinal fluid from the patients with anti-NMDAR encephalitis via inhibiting or activating Occludin/Claudin-5 or Neuregulin-1 with CRISPR/Cas9 knockout or activation plasmids and blocking MAPKs signaling pathway with inhibitors. This study will benefit to autoimmune encephalitis patients with new therapy strategy eventually.
本项目临床研究发现自身免疫性脑炎患者预后与血脑屏障(BBB)破坏密切相关。通过回顾性分析了81例成人自身免疫性脑炎患者发现延迟免疫治疗,癫痫持续状态和提高的24小时免疫球蛋白鞘内合成率是自身免疫性脑炎相关癫痫延迟撤药的独立危险因素。基础研究发现:1.NMDA过度活化NMDAR后通过Cav-1/Akt/mTOR信号通路促进Cav-1、Akt和mTOR 磷酸化,增加MMP9表达,减少紧密连接蛋白Occludin表达而破坏BBB功能。抑制Cav-1/Akt/mTOR可逆转NMDA对BBB破坏;2.NMDA受体的活化可以诱导HBEC-5i细胞中紧密连接蛋白Z0-1的表达下降从而增加紧密连接屏障的通透性,同时刺激Cav-1和ERK1/2相继磷酸化从而激活Cav-1相关的ERK1/2信号通路。抑制Cav-1相关的ERK1/2信号通路的活化可阻断NMDA受体活化介导的ZO-1表达下降和降低的跨内皮电阻。3.利用NMDAR NR1356-385肽段主动免疫成功建立了抗NMDAR脑炎小鼠模型,产生抗NMDAR抗体,并出现精神行为学改变。脑炎小鼠BBB通透性明显升高,紧密连接Claudin-5表达减少、NeuN、MAP2蛋白表达下调,存在BBB功能破坏和大脑神经元损害。PI3K/Akt信号通路参与了抗NMDAR脑炎小鼠Claudin-5的调节,予LY294002抑制PI3K/Akt通路后,下调磷酸化PI3K及Akt表达,增加Claudin-5、NeuN、MAP2蛋白表达,保护BBB完整性,稳定神经元功能。予激动剂Recilisib激活PI3K/Akt通路后,加剧了BBB破坏和神经元损害。4.抑制P38MAPK激活,可减少MMP9表达,增加紧密连接蛋白Occludin及ZO-1表达可改善脑炎小鼠BBB功能,同时可逆转脑炎小鼠脑NMDAR NR1降解,降低GFAP和TNF-α表达,减少神经元损伤。5.阻断Rho/ROCK可逆转NMDA诱导的紧密连接蛋白破坏和F-actin重新分布,减少活性氧的产生及 细胞凋亡,保护BBB;上述研究成果为抗NMDAR脑炎防治提供新的策略。
Rho/ROCK信号传导通路在HIV-1 Tat蛋白诱导血脑屏障破坏与β淀粉样蛋白沉积中的作用
-
批准号:81371333
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:黄文
-
依托单位:
HIV-1 Tat蛋白诱导血脑屏障破坏及其作用机制
-
批准号:81160152
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位:
国内基金
海外基金